<Weekly Highlight> Senate Democrats aim to include Medicare drug price negotiation authority in $3.5T infrastructure deal[1] (7/14)...

<Weekly Highlight> Pfizer to ask regulators to authorize Covid-19 vaccine booster, but CDC recommends to wait[1] (7/8) Pfizer will seek...

<Weekly Highlights> J&J Covid-19 vaccine shows promising preliminary signs of protecting against Delta variant[1] (7/1) Johnson &...

<Weekly Highlight> Delta Covid-19 variant could be dominant in US in two to three weeks[1] (6/22) The highly transmissible Delta variant...

<Weekly Highlight> Novavax Covid-19 vaccine is 90% effective, including against variants, new study shows[1] (6/14) An experimental...

<Weekly Highlight> Biden Administration recommends policy changes to secure US pharmaceutical supply chain[1] (6/8) After investigating...

<Weekly Highlight> Regeneron’s Covid-19 drug Is authorized for injection[1] (6/4) U.S. health regulators have authorized newer, more...

Weekly Highlight FDA and J&J are near a deal to resume Covid-19 vaccine production at Baltimore plant[0] (5/27) The FDA and Johnson &...

<Weekly Highlight> Getting more people vaccinated against Covid-19 means wasting doses[1] (5/21) Now that Covid-19 vaccine supplies are...

<Weekly Highlight> CDC announces that fully vaccinated people can stop wearing face masks and end physical distancing in most settings[1]...

<Weekly Highlight> U.S. supports waiver of intellectual property protection for Covid-19 vaccines[1] (5/6) The U.S. agreed to support the...

<Weekly Highlight> US will soon launch talks with WTO to overcome COVID vaccine IP issues[1] (5/3) The US top trade negotiator will begin...

<Weekly Highlight> States restart J&J Covid-19 vaccine, previously paused over blood-clotting side effect[1] (4/25) The CDC and FDA...

<Weekly Highlight> US recommends pause in Johnson & Johnson vaccinations due to concerns over rare blood clots[1] In a joint...

<Weekly Highlight> Moderna Covid-19 Vaccine Production Pace to Increase at Contract Manufacturer Catalent[1] (4/6) Catalent, a contract...